Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...
New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.
7don MSNOpinion
Obesity is more than a cosmetic concern. It’s a chronic disease that can be treated with drugs like semaglutide (Wegovy) and ...
For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...
As 2025 ushers in a new era of weight loss resolutions, many Americans are abandoning traditional gym-first approaches in ...
By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers found. Common adverse side effects from the drugs included nausea, vomiting, ...
In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...
According to that study, those who use GLP-1 dugs, such as Wegovy and Ozempic, cut their grocery spend by about 6% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback